Freedom Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-805
| Closed | -$218K | – | 794 |
|
|
2024
Q1 | $218K | Sell |
805
-343
| -30% | -$81.9K | 0.02% | 715 |
|
|
2023
Q4 | $271K | Sell |
1,148
-269
| -19% | -$52.9K | 0.02% | 626 |
|
|
2023
Q3 | $278K | Buy |
1,417
+4
| +0.3% | +$821 | 0.03% | 535 |
|
|
2023
Q2 | $297K | Sell |
1,413
-358
| -20% | -$71.2K | 0.03% | 546 |
|
|
2023
Q1 | $357K | Buy |
1,771
+574
| +48% | +$130K | 0.04% | 501 |
|
|
2022
Q4 | $261K | Sell |
1,197
-25
| -2% | -$5.46K | 0.03% | 608 |
|
|
2022
Q3 | $240K | Sell |
1,222
-39
| -3% | -$8.42K | 0.03% | 615 |
|
|
2022
Q2 | $270K | Buy |
1,261
+7
| +0.6% | +$1.71K | 0.03% | 607 |
|
|
2022
Q1 | $356K | Sell |
1,254
-678
| -35% | -$209K | 0.03% | 574 |
|
|
2021
Q4 | $728K | Buy |
1,932
+58
| +3% | +$22.5K | 0.05% | 435 |
|
|
2021
Q3 | $773K | Sell |
1,874
-195
| -9% | -$81K | 0.06% | 392 |
|
|
2021
Q2 | $765K | Sell |
2,069
-109
| -5% | -$36.4K | 0.06% | 408 |
|
|
2021
Q1 | $631K | Sell |
2,178
-595
| -21% | -$165K | 0.05% | 447 |
|
|
2020
Q4 | $693K | Sell |
2,773
-300
| -10% | -$71.4K | 0.08% | 256 |
|
|
2020
Q3 | $696K | Sell |
3,073
-600
| -16% | -$125K | 0.08% | 222 |
|
|
2020
Q2 | $640K | Sell |
3,673
-1,166
| -24% | -$186K | 0.07% | 217 |
|
|
2020
Q1 | $755K | Buy |
4,839
+1,630
| +51% | +$244K | 0.07% | 242 |
|
|
2019
Q4 | $490K | Sell |
3,209
-2,130
| -40% | -$295K | 0.04% | 349 |
|
|
2019
Q3 | $707K | Buy |
5,339
+1,448
| +37% | +$194K | 0.06% | 280 |
|
|
2019
Q2 | $552K | Sell |
3,891
-2,467
| -39% | -$335K | 0.05% | 336 |
|
|
2019
Q1 | $923K | Sell |
6,358
-799
| -11% | -$105K | 0.07% | 252 |
|
|
2018
Q4 | $810K | Buy |
7,157
+1,608
| +29% | +$201K | 0.06% | 309 |
|
|
2018
Q3 | $692K | Buy |
5,549
+169
| +3% | +$20.9K | 0.04% | 419 |
|
|
2018
Q2 | $604K | Buy |
+5,380
| New | +$582K | 0.04% | 475 |
|
|
2017
Q4 | – | Sell |
-4,238
| Closed | -$458K | – | 1139 |
|
|
2017
Q3 | $458K | Buy |
4,238
+428
| +11% | +$44K | 0.03% | 636 |
|
|
2017
Q2 | $385K | Buy |
3,810
+357
| +10% | +$32.9K | 0.02% | 676 |
|
|
2017
Q1 | $311K | Buy |
+3,453
| New | +$293K | 0.02% | 747 |
|
|
2016
Q4 | – | Sell |
-3,485
| Closed | -$290K | – | 992 |
|
|
2016
Q3 | $290K | Buy |
3,485
+98
| +3% | +$8.21K | 0.02% | 654 |
|
|
2016
Q2 | $279K | Buy |
3,387
+372
| +12% | +$30.6K | 0.02% | 616 |
|
|
2016
Q1 | $229K | Buy |
+3,015
| New | +$223K | 0.02% | 681 |
|
Other funds holding CRL
MG
SCA